注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
该基金的投资目标为资本增值。该基金主要地投资位于美国及其他国家的生物科技公司和研究发展公司的股份,及在较少程度上投资于全世界任何类别的机构所发行的债务证券。就该基金的投资目标而言,生物科技公司是指其最少50%的盈利乃由生物科技业务所提供,或公司在最近的财政年度将至少50%的资产投资发展该等业务。
名称 | 标题 | 任期 | 至 |
---|---|---|---|
Akiva Felt | - | 2020 | now |
背景介紹 | Mr. Felt has been a portfolio manager, providing research and advice on the purchases and sales of individual securities and portfolio risk assessment. He joined Franklin Templeton in 2018. Prior to joining Franklin Templeton, Mr. Felt was a Senior Research Analyst with Asymmetry Capital, a healthcare focused hedge fund. He has covered the biotechnology sector since 2007 in increasing capacities on the sell-side, most recently as Managing Director for Oppenheimer & Co. | ||
Wendy Lam | Portfolio Manager | 2018 | now |
背景介紹 | Ms. Lam has joined Franklin Templeton Investments in 2016. Prior to joining Franklin Templeton, Ms. Lam was an Executive Director and Senior Analyst covering large-cap biotechnology for Oppenheimer & Co and had been an Equity Research Associate at Bank of America Merrill Lynch, Morgan Stanley and Oppenheimer & Co. Ms. Lam has a Ph.D degree. | ||
Evan S. McCulloch | Vice President | 2000 | now |
背景介紹 | Mr. McCulloch, CFA, joined Franklin Templeton Investments in 1992. | ||
Steven Kornfeld | Portfolio Manager | 2015 | 2020 |
背景介紹 | Steven Kornfeld is VP, Research Analyst and Portfolio Manager with Franklin Equity Group. He specializes in research analysis of the pharmaceutical industry and is a member of the Franklin Core/Hybrid team. Prior to joining Franklin Templeton Investments in January 2001, Mr. Kornfeld most recently worked in private equity and previously as a sell-side research analyst where he specialized in covering emerging growth companies. He holds an MBA from Northwestern University and a bachelor’s degree from the Wharton School of Business at the University of Pennsylvania. He is a CFA®* Charterholder. | ||
Jerel A. Banks | senior equity research analyst | 2012 | 2015 |
背景介紹 | JEREL A. Banks has been a portfolio manager of the Fund since September 2012, providing research and advice on the purchases and sales of individual securities and portfolio risk assessment. He joined Franklin Templeton Investments in 2012. Prior to joining Franklin Templeton Investments, he was a senior equity research analyst at Sectoral Asset Management and Apothecary Capital and an equity research associate at Capital Research and Management. | ||
Vincent Xiang | Manager | 2004 | 2011 |
背景介紹 | Xiang is a manager of the fund providing research and advice on the purchases and sales of individual securities and portfolio risk assessment. He joined Franklin Templeton Investments in 2004. Previously, Xiang was a vice president of business development at Genyous Life Sciences, Inc. He also worked on deal sourcing, due diligence and strategic planning at BioAdvance and as a senior analyst for Acacia Research Corporation. | ||
Kurt von Emster | Portfolio Manager | 2000 | 2000 |
背景介紹 | Von Emster is currently a portfolio manager with Franklin Advisers. He joined the firm in 1989 as a management trainee and securities analyst. Previously, he was a purchasing agent for the University of California at Santa Barbara's Marine Science Institute. Von Emster is a Chartered Financial Analyst and a member of the Security Analysts of San Francisco. |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核